Atrial fibrillation therapy
https://libcat.nshealth.ca/en/permalink/provcat33699
Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm, editors.
--London:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.
- Available Online
- View e-Book
- Corporate Author
- International Society of Cardiovascular Pharmacotherapy
- Other Authors
- Dan, G. Andrei
- Bayés de Luna, Antoni
- Camm, A. John
- Responsibility
- Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm, editors
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xiv, 188 pages)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9781447154754 (electronic bk.)
- 9781447154747
- Subjects (MeSH)
- Atrial Fibrillation - drug therapy
- Subjects (LCSH)
- Atrial fibrillation
- Cardiology
- Abstract
- The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.
- Contents
- Epidemiology, burden and unmet needs in atrial fibrillation -- Inside molecular mechanisms and pharmacological targets of atrial fibrillation -- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation -- Upstream therapy in the treatment of atrial fibrillation -- Drug therapy for rhythm and rate control in atrial fibrillation -- Changing the paradigm to understand and manage atrial fibrillation -- Guidelines and current recommendations in atrial fibrillation.
- Format
- e-Book
- Location
- Online
Cardiac drugs in pregnancy
https://libcat.nshealth.ca/en/permalink/provcat33787
Karen Sliwa, John Anthony, editors.
--London:
Springer ; ISCP
, c2014.
- Available Online
- View e-Book
- Location
- Online
In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease d…
- Available Online
- View e-Book
- Corporate Author
- International Society of Cardiovascular Pharmacotherapy
- Other Authors
- Sliwa, Karen
- Anthony, John
- Responsibility
- Karen Sliwa, John Anthony, editors
- Place of Publication
- London
- Publisher
- Springer ; ISCP
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xii, 131 pages)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9781447154723 (electronic bk.)
- 9781447154716
- Subjects (MeSH)
- Cardiovascular Agents - therapeutic use
- Pregnancy Complications, Cardiovascular - drug therapy
- Pregnancy
- Subjects (LCSH)
- Obstetrical pharmacology
- Cardiovascular agents
- Cardiovascular diseases in pregnancy
- Cardiology
- Obstetrics/Perinatology
- Maternal and Child Health
- Pharmacotherapy
- Abstract
- In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy.
- Contents
- General principles and guidelines -- Management of hypertension -- Management of heart failure pre- and postpartum -- Management of coronary artery disease and arrhythmias -- Anticoagulation in pregnancy -- Obstetric drugs in the management of cardiovascular disease.
- Format
- e-Book
- Location
- Online
Pharmacological treatment of acute coronary syndromes
https://libcat.nshealth.ca/en/permalink/provcat33393
Pablo Avanzas, Peter Clemmensen, editors.
--London:
Springer ; ISCP
, c2014.
- Available Online
- View e-Book
- Location
- Online
Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series, and this particular title within the series, is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action, the possible adverse effects, and…
- Available Online
- View e-Book
- Corporate Author
- International Society of Cardiovascular Pharmacotherapy
- Other Authors
- Avanzas, Pablo
- Clemmensen, Peter
- Responsibility
- Pablo Avanzas, Peter Clemmensen, editors
- Place of Publication
- London
- Publisher
- Springer ; ISCP
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xvi, 245 pages)
- Series Title
- Current cardiovascular therapy
- ISBN
- 9781447154242 (electronic bk.)
- 9781447154235
- Subjects (MeSH)
- Acute Coronary Syndrome - drug therapy
- Anticoagulants - therapeutic use
- Platelet Aggregation Inhibitors - therapeutic use
- Subjects (LCSH)
- Cardiovascular pharmacology
- Heart - Diseases - Chemotherapy
- Coronary heart disease
- Electrocardiography
- Pharmacology
- Acute coronary syndrome - Diagnosis
- Abstract
- Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series, and this particular title within the series, is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action, the possible adverse effects, and the management of patients prescribed these drugs.
- Contents
- 1. Anti-ischemic Therapy -- 2. Antiaggregant Therapy: New potent P2Y12 inhibitors -- 3. Anticoagulation Therapy: Heparins and Factor Xa inhibitors -- 4. Secondary prevention in ACS: The role of novel oral anticoagulants -- 5. American versus European guidelines: Critical appraisal -- 6. Triple therapy: Risky but sometimes necessary -- 7. Management of bleeding complications.
- Format
- e-Book
- Location
- Online
